A Note from Dr. Mario Raviglione

10 Feb 2010
by Working Group

Dr. Mario Raviglione
Dr. Mario Raviglione

Never before in the recent history of tuberculosis research have we been so close to seeing the arrival of new drug breakthroughs that could help reshape the course of TB care and control in a direct and positive way. WHO is fully supportive of the impressive efforts and energies that have been invested by the scientific community over the last decade in the search for new and more effective anti-TB drugs.

The contribution to TB control from this research community will have a far-reaching impact on the lives of millions in the future, and we all hope that the continued challenges in developing new drugs can be overcome swiftly as the need is urgent.

We welcome the launch of this website and look forward to accessing regular up-to-date information about the progress and achievements of the New Drug working group and helping to share this information with the world at large.

— Dr. Mario Raviglione, Director of WHO Stop TB Department

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...